Circular RNA regulatory role in pathological cardiac remodelling
Alessia Bibi,Monika Bartekova,Shrey Gandhi,Simona Greco,Alisia Madè,Moumita Sarkar,Victoria Stopa,Spyros Tastsoglou,David de Gonzalo‐Calvo,Yvan Devaux,Costanza Emanueli,Artemis G. Hatzigeorgiou,A. Yaël Nossent,Zhichao Zhou,Fabio Martelli,CardioRNA COST Action CA17129 and AtheroNET COST Action CA21153
DOI: https://doi.org/10.1111/bph.16434
IF: 7.3
2024-06-05
British Journal of Pharmacology
Abstract:Cardiac remodelling involves structural, cellular and molecular alterations in the heart after injury, resulting in progressive loss of heart function and ultimately leading to heart failure. Circular RNAs (circRNAs) are a recently rediscovered class of non‐coding RNAs that play regulatory roles in the pathogenesis of cardiovascular diseases, including heart failure. Thus, a more comprehensive understanding of the role of circRNAs in the processes governing cardiac remodelling may set the ground for the development of circRNA‐based diagnostic and therapeutic strategies. In this review, the current knowledge about circRNA origin, conservation, characteristics and function is summarized. Bioinformatics and wet‐lab methods used in circRNA research are discussed. The regulatory function of circRNAs in cardiac remodelling mechanisms such as cell death, cardiomyocyte hypertrophy, inflammation, fibrosis and metabolism is highlighted. Finally, key challenges and opportunities in circRNA research are discussed, and orientations for future work to address the pharmacological potential of circRNAs in heart failure are proposed.
pharmacology & pharmacy